Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,665 across all filing types
Latest filing 2019-08-14 Regulatory Filings
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Response to ASX Appendix 4C Query 5 pages 717.1KB
Regulatory Filings Classification · 95% confidence The document is a formal response from Admedus Ltd to the ASX (Australian Securities Exchange) regarding an Appendix 4C query. Appendix 4C is a quarterly cash flow report required by the ASX for listed entities. The document addresses specific questions from the ASX about the company's negative operating cash flows, recapitalisation plans, and compliance with ASX Listing Rules. The content is a detailed reply to a regulatory inquiry rather than a financial report itself. It does not contain actual financial statements or comprehensive financial data but rather explanations and confirmations related to the company's financial condition and compliance. The document is also a direct communication with the ASX, indicating it is a regulatory filing. Therefore, this document fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2019-08-14 English
Notice to terminate distribution agreement 1 page 7
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 8 August 2019 regarding the termination of a distribution agreement between Admedus Limited and arcomed ag. It is a company announcement about a business arrangement change, specifically the termination of a distribution agreement. The document does not contain financial statements, audit information, management discussion, or any regulatory filings related to financial results or governance. It is not a report, transcript, or detailed presentation. It is a straightforward corporate announcement about a contract termination and future updates. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous company announcements that do not fit other specific categories.
2019-08-07 English
Change in substantial holding 3 pages 240.2KB
Regulatory Filings
2019-08-06 English
Extension for Voluntary Suspension 1 page 78.9KB
Regulatory Filings Classification · 100% confidence The document is a letter from the company to the ASX (Australian Securities Exchange) requesting an extension of a voluntary suspension of trading of its securities. It discusses the status of the company's recapitalisation plan and the expected duration of the suspension. There are no financial statements, no detailed financial data, no earnings information, no management discussion of results, no audit information, no voting results, no legal proceedings, no merger or acquisition details, and no presentation materials. The document is short (2016 characters) and is an announcement related to trading status and compliance with listing rules. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2019-08-04 English
Appendix 4C - quarterly 7 pages 239.6KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'QUARTERLY REPORT – APPENDIX 4C FOR THE PERIOD TO 30 JUNE 2019' and contains detailed financial data including revenue, cash flows from operating, investing, and financing activities, and a consolidated statement of cash flows for the quarter ended 30 June 2019. It also includes management commentary on business highlights, sales performance, debt facilities, and estimated cash outflows for the next quarter. The document is approximately 15,000 characters long, indicating it is a substantive report rather than a brief announcement. The presence of detailed financial statements and analysis for a period shorter than a full fiscal year aligns with the definition of an Interim / Quarterly Report (IR). Therefore, the document should be classified as an Interim / Quarterly Report (IR). Q2 2019
2019-07-30 English
Appendix 3B 9 pages 221.9KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and references ASX rules related to new securities issuance and quotation. It details the class, number, terms, and issue dates of securities, including options issued under an Employee Incentive Plan. The document is a formal announcement to the ASX regarding the issuance and quotation of additional securities. It does not contain financial statements, management discussion, or audit information. It is not a report but an official notification of a capital change event. Therefore, it fits the category of Share Issue/Capital Change announcements.
2019-07-15 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.